Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients
Digestive Diseases and Sciences · 2024
DOI: 10.1007/s10620-024-08365-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Hua Xin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine, The First Affiliated Hospital of Jiamusi University, Jiamusi, 154000, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tumor-Associated Macrophages, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Health Commission of Heilongjiang Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Gastric cancer (GC) remains one of the most prevalent malignant tumors worldwide. At present, tumor-associated macrophages (TAMs) are essential in the progression, metastasis, and drug resistance of tumors. Therefore, TAMs can be a crucial target for tumor treatment. AIMS: We intended to investigate the TAM characteristics in GC and develop a risk signature based on TAM to predict the prognosis of GC patients. METHODS: The single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq data were acquired from a publicly available database. We utilized the Seurat pipeline to process the scRNA-seq data and determine TAM cell types using marker genes. Univariate Cox regression analysis was utilized to examine TAM-related prognostic genes, and then we employed Lasso-Cox regression analysis, and Multivariate Cox regression analysis established a novel risk profile to forecast the clinical value of the model with a new nomogram combining risk profiles and clinicopathological characteristics. RESULTS: The current study employed scRNA-seq data to identify five TAM clusters in GC, among which four were significantly associated with GC prognosis. Accordingly, we further developed a TAM-related risk signature utilizing nine genes. After evaluation, our model accurately predicted the prognosis of gastric cancer. Generally, GC patients with low TAMS scores exhibited a more favorable prognosis, greater benefits from immunotherapy, and higher levels of immune cell infiltration. CONCLUSIONS: The prognosis of GC can be effectively predicted by TAM-based risk signatures, and the signature may provide a new perspective for comprehensively guiding clinical diagnosis, prediction, and immunotherapy for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Medicine, The First Affiliated Hospital of Jiamusi University, Jiamusi, 154000, Heilongjiang Province, China.
- Clinical Medicine Department, Jiamusi University, Jiamusi, 154000, Heilongjiang Province, China.
- Laboratory Medicine, The First Affiliated Hospital of Jiamusi University, Jiamusi, 154000, Heilongjiang Province, China. cgl27030754@163.com.
- Clinical Medicine Department, Jiamusi University, Jiamusi, 154000, Heilongjiang Province, China. cgl27030754@163.com.
Förderung
- Health Commission of Heilongjiang Province
Zitieren
APA
Xin, H., Chen, Y., Niu, H., Li, X., Gai, X., & Cui, G. (2024). Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08365-1
Vancouver
Xin H, Chen Y, Niu H, Li X, Gai X, Cui G. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08365-1
BibTeX
@article{Xin2024,
author = {Xin, Hua and Chen, Yu and Niu, Honglin and Li, Xuebin and Gai, Xuejie and Cui, Guoli},
title = {Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients},
journal = {Digestive Diseases and Sciences},
year = {2024},
doi = {10.1007/s10620-024-08365-1}
}
EUVIMED